Floatz logo

Lactate

Metastatic Urothelial Carcinoma

University of Texas Southwestern Medical CenterSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Metastatic Urothelial Carcinoma cohort.

Asset / SponsorPhaseRating
Irinotecan
Pfizer
Phase 3BB
(+)-VINCRISTINE
Pfizer
Phase 3BB
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Vasgene Therapeutics, Inc
Phase 2/3BB
Durvalumab
Alliance for Clinical Trials in Oncology
Phase 3BB
Olaparib
Rahul Aggarwal
Phase 2BB

View all 21 →

Same molecule, other indications

Lactate is also rated in:

stroke disorderDormant
CCC
Indicative ·
51 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
C
Indicative ·
36 / 100
View asset →
urothelial carcinomaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →